Table 4.
Changes in SCFAs contents produced during fermentation.
| SCFAs(mmol/L) | Time | CON | INU | LDSPs |
|---|---|---|---|---|
| Acetic acid | 0 | 2.76 ± 0.10d, A | 2.76 ± 0.10d, A | 2.76 ± 0.10d, A |
| 6 | 5.02 ± 0.12a, C | 7.18 ± 0.17c, B | 20.72 ± 0.05b, A | |
| 12 | 4.57 ± 0.05c, C | 11.75 ± 0.11b, B | 20.09 ± 0.13c, A | |
| 24 | 4.90 ± 0.23b, C | 28.64 ± 0.17a, B | 18.70 ± 0.01a, A | |
| Propionic acid | 0 | 0.86 ± 0.03d, A | 0.86 ± 0.03d, A | 0.86 ± 0.03d, A |
| 6 | 1.75 ± 0.10c, C | 10.16 ± 0.29c, B | 14.60 ± 0.09c, A | |
| 12 | 3.06 ± 0.03b, C | 11.71 ± 0.40b, B | 17.78 ± 0.14b, A | |
| 24 | 4.43 ± 0.02a, C | 15.78 ± 0.20a, B | 26.31 ± 0.16a, A | |
| n-Butyric acid | 0 | 0.76 ± 0.02c, A | 0.76 ± 0.02d, A | 0.76 ± 0.02d, A |
| 6 | 0.47 ± 0.05d, C | 1.17 ± 0.13b, B | 15.32 ± 0.18c, A | |
| 12 | 1.80 ± 0.15a, C | 1.57 ± 0.04a, B | 34.44 ± 0.04b, A | |
| 24 | 0.89 ± 0.07b, C | 1.12 ± 0.01c, B | 45.10 ± 0.29a, A | |
| i-Butyric acid | 0 | ND | ND | ND |
| 6 | 0.06 ± 0.03b, B | ND | 0.12 ± 0.05b, A | |
| 12 | 0.20 ± 0.11a, A | 0.03 ± 0.01, B | 0.32 ± 0.01a, A | |
| 24 | 0.19 ± 0.06a, B | 0.13 ± 0.03, B | 0.40 ± 0.09a, A | |
| n-Valeric acid | 0 | ND | ND | ND |
| 6 | 0.21 ± 0.37c, A | ND | ND | |
| 12 | 0.76 ± 0.66b, C | 0.60 ± 0.21b, B | 2.97 ± 0.19a, A | |
| 24 | 1.83 ± 0.15a, B | 1.18 ± 0.23a, A | 1.91 ± 0.10b, A | |
| i-Valeric acid | 0 | ND | ND | ND |
| 6 | ND | ND | ND | |
| 12 | ND | 1.00 ± 0.05a, B | 1.42 ± 0.31a, A | |
| 24 | ND | ND | ND | |
| Total acid | 0 | 4.39 ± 0.12d, A | 4.39 ± 0.12d, A | 4.39 ± 0.12d, A |
| 6 | 7.46 ± 0.13c, C | 18.51 ± 0.08c, B | 50.64 ± 0.05c, A | |
| 12 | 10.19 ± 0.16b, C | 26.63 ± 0.19b, B | 76.69 ± 0.09b, A | |
| 24 | 12.05 ± 0.03a, C | 46.72 ± 0.21a, B | 92.02 ± 0.13a, A |
Data are expressed as mean ± SD (n = 5), a–d (lowercase letter) mean significant differences among different times (p < 0.05) in the same group, and A–C (capital letter) represent significant differences among different groups (p < 0.05) at the same time. CON, the blank control (no additional carbon source supplement); INU, the positive control (INU supplement), and LDSPs, the experimental group (LDSPs supplement); ND, not detected.